Belite Bio BLTE
NASDAQ BLTE
$188.52 +17.43 (+10.19%)
As of: Sep 4, 2026 · 3:22 PM EDT

Belite Bio (BLTE) Net Shares Issued and Repurchased (2020 - 2025)

Analysis

Belite Bio (BLTE) Net Shares Issued and Repurchased (2020 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Shares Issued and Repurchased (Qtr)
1 Vertex Pharmaceuticals 138.43 Bn 130.58 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.34 Bn 58.15 Bn 1.37 Bn -
4 Moderna 57.98 Bn 52.85 Bn 52.00 Mn -
5 Revolution Medicines 43.98 Bn 43.98 Bn - -
6 BeOne Medicines 39.92 Bn 34.82 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.42 Bn 32.11 Bn 992.69 Mn -
8 Royalty Pharma 28.42 Bn 27.58 Bn - -
9 Insmed 27.36 Bn 26.20 Bn 358.27 Mn -
10 Belite Bio 6.26 Bn 6.26 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 1.15 Mn
Dec 31, 2024 1.28 Mn
Dec 31, 2023 1.02 Mn
Dec 31, 2022 1.70 Mn
Dec 31, 2021 748,667.00
Dec 31, 2020 2.81 Mn